Anticoagulant and Fibrinolytic Therapy Summary

Anticoagulant and Fibrinolytic Therapy Summary is organized by CEUfast, Inc.. This course has been approved for a maximum of 5 Contact Hours including 5 Advanced Pharmacology Hours.

Last Updated: 2/18/2022
This course will be updated or discontinued on or before Tuesday, March 26, 2024

Outcomes
This course will provide professional nurses with the information they need to safely and effectively administer anticoagulant and fibrinolytic drugs.

Objectives
After completing this continuing education course, the learner will be able to:

• Identify a common indication of the use of warfarin.
• Identify a common indication for the use of heparin.
• Identify a common indication for the use of fibrinolytic drugs.
• Identify two tests that are used to measure coagulation.
• Identify the coagulation tests that are used to monitor therapy with heparin and aspirin.
• Identify the mechanism of action of aspirin, heparin, the DOACs, and warfarin.
• Identify a common adverse effect of aspirin, heparin, the DOACs, and heparin.
• Identify drugs used to reverse the anticoagulant effects of heparin and warfarin.
• Identify laboratory tests that should be measured before starting anticoagulant therapy.
• Identify two major contraindications for fibrinolytic therapy.